Rating History for Millendo Therapeutics Inc. (MLND) by Leerink

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/6/2021 Joseph Schwartz Downgrade Market Perform
(Outperform)
2.00
(N/A)
2.06
(1.06)
-48.54% Details